Proventus Zdrowie i Kapitałsp. z o.o.

Specialist medical practice activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2006-11-10
Share capital
200,000.00 PLN
Registered address
ul. św. Teresy Od Dzieciątka Jezus 91/206, 91-341 Łódź, Poland
Electronic delivery address
AE:PL-13800-44274-FCERC-29

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 312 days for 2021).

  • 2025not filed
  • 202414/07/2025
  • 202311/07/2024
  • 202212/07/2023
  • 202123/05/2023
  • 202017/01/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Top 58%
Division · Human health activities4,935 / 7,730
Top 64%
Top 60%
Voivodeship · Łódzkie9,872 / 23,391
Top 42%
Country · Poland202,324 / 495,860
Top 41%

Results vs industry

Revenue
This companyUSD 326.27kMedianUSD 443.52kAverageUSD 1.75m
Net profit
This companyUSD -51.73kMedianUSD 14.31kAverageUSD 129.52k
Operating costs
This companyUSD 339.61kMedianUSD 397.10kAverageUSD 1.56m
Assets
This companyUSD 117.99kMedianUSD 173.92kAverageUSD 1.02m

National Health Fund (NFZ) contracts

Proventus Zdrowie i Kapitał has been an NFZ healthcare provider since 2010. In 2026 it is performing 1 contract worth USD 250.28k. All its contracts were worth USD 2.84m in total.

NFZ contract value by year (in k USD)

Type of careNFZ branchContractsValue in 2026
Outpatient specialist carełódzkie1USD 250.28k

NFZ waiting lists

This company's facilities run 2 NFZ waiting lists. Waiting time forecast by NFZ, as of 08.10.2026.

ServiceWaiting time
Oral and maxillofacial surgery clinic15 days
Oncological surgery clinic21 days

Authorized Representatives

Aneta Dorota Neskoromna – Management Board Member

Manner of representation

If a multi-member management board is appointed, each member of the management board, as well as the commercial proxy, if appointed, is independently authorised to make declarations of will concerning the company's proprietary rights and obligations with a value not exceeding the equivalent of EUR 50,000, calculated according to the average euro exchange rate announced by the NBP on the date of making the declarations of will; whereas if their value exceeds EUR 50,000, joint action by two members of the management board or by one member of the management board jointly with the commercial proxy is required.

Ownership

OwnerSharesShare valueStake
Aneta Dorota Neskoromnaage 54
2,530$34,170.7263.25%
Urszula Neskoromnaage 84
1,470$19,854.1336.75%

Aneta Dorota Neskoromna and Urszula Neskoromna hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2006-12-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$0

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Miejskie Centrum Medyczne Śródmieściesp. z o.o.
Genossp. z o.o.
Sportosp. z o.o.
Mariposa Medicasp. z o.o.
Stheticasp. z o.o.
Proph-Med Nzozsp. z o.o.
Snzoz Med Medsp. z o.o.
Medevac Pawlikowskisp. z o.o. + limited partnership
Friszsp. z o.o.
Mizmedsp. z o.o.

Change history

DateEvent
2025-02-17Address change
2015-03-31Share capital increase
2015-03-31PKD change
2009-02-16Switch to PKD 2007
2007-09-26Share capital increase

FAQ

Last updated: 2026-04-13